Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(3 sites)

United States

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts